国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
14期
2106-2109
,共4页
张莉%邵志坚%陈琼英%徐骅
張莉%邵誌堅%陳瓊英%徐驊
장리%소지견%진경영%서화
恶性肿瘤%社区干预%IKAP护理%生活质量
噁性腫瘤%社區榦預%IKAP護理%生活質量
악성종류%사구간예%IKAP호리%생활질량
Cancer%Community intervention%IKAP Nurse%Quality of life (QOL)
目的 探讨在社区干预中运用IKAP护理模式对恶性肿瘤患者生活质量的影响.方法 将128例社区内的恶性肿瘤患者分成干预组及对照组,分别采用IKAP护理模式和普通护理模式.IKAP组65例采用IKAP模式(即信息一知识一信念一行为理论模式)进行社区护理干预,对照组63例予普通护理.每6个月统计两组GQOLI评分至12个月,并对结果进行统计学比较.结果 干预前两组GQOLI各维度评分及总分之间差异无统计学意义(P>0.05),干预后两组GQOLI各维度评分及总分之间差异有统计学意义(P<0.05).结论 在社区干预中运用IKAP护理模式对恶性肿瘤患者的生活质量有较明显的改善作用.
目的 探討在社區榦預中運用IKAP護理模式對噁性腫瘤患者生活質量的影響.方法 將128例社區內的噁性腫瘤患者分成榦預組及對照組,分彆採用IKAP護理模式和普通護理模式.IKAP組65例採用IKAP模式(即信息一知識一信唸一行為理論模式)進行社區護理榦預,對照組63例予普通護理.每6箇月統計兩組GQOLI評分至12箇月,併對結果進行統計學比較.結果 榦預前兩組GQOLI各維度評分及總分之間差異無統計學意義(P>0.05),榦預後兩組GQOLI各維度評分及總分之間差異有統計學意義(P<0.05).結論 在社區榦預中運用IKAP護理模式對噁性腫瘤患者的生活質量有較明顯的改善作用.
목적 탐토재사구간예중운용IKAP호리모식대악성종류환자생활질량적영향.방법 장128례사구내적악성종류환자분성간예조급대조조,분별채용IKAP호리모식화보통호리모식.IKAP조65례채용IKAP모식(즉신식일지식일신념일행위이론모식)진행사구호리간예,대조조63례여보통호리.매6개월통계량조GQOLI평분지12개월,병대결과진행통계학비교.결과 간예전량조GQOLI각유도평분급총분지간차이무통계학의의(P>0.05),간예후량조GQOLI각유도평분급총분지간차이유통계학의의(P<0.05).결론 재사구간예중운용IKAP호리모식대악성종류환자적생활질량유교명현적개선작용.
Objective To explore the comprehensive efficacy of IKAP nursing in improving the quality of life (QOL) of patients with malignant cancer in community intervention.Methods 128 cases with malignant cancer were divided into intervention group (IKAP nursing) with 65 cases,and control group (general nursing) with 63 cases.IKAP form (information-knowledge-attitude-practice) was carried out for the cases of intervention group while general form in control group.General quality of life inventory (GQOLI) scores were measured and statistically compared every 6 months in two groups.Results GQOLI scores between the intervention group and control group had no significant difference before the intervention (P > 0.05),there were significant differences in the intervention group compared with the control group (P < 0.05) after the IKAP nursing intervention.Conclusion IKAP nursing intervention can obviously improve the QOL of the patients with malignant cancer in community.